Insider Transactions in Q2 2023 at Agilon Health, Inc. (AGL)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2023
|
Silvana Battaglia Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,963
+50.0%
|
-
|
|
Jun 15
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-19.08%
|
$337,500
$18.73 P/Share
|
|
Jun 15
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+16.02%
|
$56,250
$3.79 P/Share
|
|
Jun 14
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-6.74%
|
$337,500
$18.57 P/Share
|
|
Jun 14
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+5.93%
|
$56,250
$3.53 P/Share
|
|
May 18
2023
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
94,173,804
-48.5%
|
$1,883,476,080
$20.8 P/Share
|
|
May 16
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-23.91%
|
$575,000
$23.14 P/Share
|
|
May 16
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.3%
|
$75,000
$3.0 P/Share
|
|
May 15
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-23.91%
|
$575,000
$23.79 P/Share
|
|
May 15
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.3%
|
$75,000
$3.0 P/Share
|
|
May 15
2023
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
437,504
-0.22%
|
-
|
|
May 09
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
4,500
-1.48%
|
$117,000
$26.15 P/Share
|
|
May 09
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+1.46%
|
$13,500
$3.0 P/Share
|
|
Apr 20
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
500
-0.17%
|
$13,000
$26.15 P/Share
|
|
Apr 20
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+0.17%
|
$1,500
$3.0 P/Share
|
|
Apr 19
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.82%
|
$135,000
$27.33 P/Share
|
|
Apr 19
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.62%
|
$15,000
$3.0 P/Share
|
|
Apr 18
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-23.91%
|
$700,000
$28.05 P/Share
|
|
Apr 18
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.3%
|
$75,000
$3.0 P/Share
|
|
Apr 17
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-12.15%
|
$700,000
$28.12 P/Share
|
|
Apr 17
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+10.18%
|
$50,000
$2.0 P/Share
|
|
Apr 14
2023
|
Steven Sell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,216
-5.02%
|
$118,048
$28.46 P/Share
|
|
Apr 14
2023
|
Steven Sell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
35,138
+29.52%
|
-
|
|
Apr 14
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,043
-3.68%
|
$85,204
$28.46 P/Share
|
|
Apr 14
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,961
+21.01%
|
-
|
|
Apr 14
2023
|
Girish Venkatachaliah Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,357
-3.59%
|
$37,996
$28.46 P/Share
|
|
Apr 14
2023
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,961
+36.78%
|
-
|
|
Apr 14
2023
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+0.23%
|
-
|
|
Apr 14
2023
|
John William Wulf Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+4.18%
|
-
|
|
Apr 14
2023
|
Timothy Bensley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,871
-7.55%
|
$80,388
$28.46 P/Share
|
|
Apr 14
2023
|
Timothy Bensley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,981
+22.4%
|
-
|
|
Apr 14
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,497
-1.15%
|
$97,916
$28.46 P/Share
|
|
Apr 14
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,353
+8.0%
|
-
|
|
Apr 14
2023
|
Priscilla Kasenchak Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,393
+36.19%
|
-
|
|
Apr 14
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,312
-2.19%
|
$36,736
$28.46 P/Share
|
|
Apr 14
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,393
+6.84%
|
-
|
|
Apr 14
2023
|
Sharad Mansukani Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+0.45%
|
-
|
|
Apr 14
2023
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+45.63%
|
-
|
|
Apr 14
2023
|
Karen Mc Loughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+25.94%
|
-
|
|
Apr 14
2023
|
Clay Richards Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+12.0%
|
-
|
|
Apr 14
2023
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+36.86%
|
-
|